​

Funding Round

Series B - EGenesis

Series B - EGenesis

Investment Firm

Overview

EGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.

Announced Date

Nov 07, 2019

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Fresenius Medical Care

Fresenius Medical Care

No designation

Participant Investors

7

Investor Name
Participant InvestorAlta Partners
Participant InvestorFresenius Medical Care
Participant InvestorARCH Venture Partners
Participant InvestorWellington Partners
Participant InvestorKhosla Ventures

Round Details and Background

EGenesis raised $100000000 on 2019-11-07 in Series B

EGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 07, 2019
Series B - EGenesis
7-100.0M
Mar 02, 2021
Series C - EGenesis
18-125.0M
Mar 16, 2017
Series A - EGenesis
11-38.0M
Aug 23, 2016
Convertible Note - EGenesis
-2.0M

Recent Activity

There is no recent news or activity for this profile.